John Chalmers
Director/Miembro de la Junta en Prognomix, Inc. .
Cargos activos de John Chalmers
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - | - |
Historial de carrera de John Chalmers
Antiguos cargos conocidos de John Chalmers.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
International Society of Hypertension
 International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Presidente | - | - |
| Presidente | - | - | |
Royal Prince Alfred Hospital
 Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | 01/01/1972 | - |
| National Health & Medical Research Council | Presidente | - | - |
| Presidente | - | - | |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Formación de John Chalmers.
| The University of Sydney | Undergraduate Degree |
| The University of New South Wales | Doctorate Degree |
Estadísticas
Internacional
| Australia | 5 |
| Canadá | 2 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chairman | 2 |
| President | 2 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Royal Prince Alfred Hospital
Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Health Services |
| National Health & Medical Research Council | Government |
International Society of Hypertension
International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Commercial Services |
- Bolsa de valores
- Insiders
- John Chalmers
- Experiencia
